Candida tropicalis is a yeast species that can be part of the normal human microbiota, particularly in the gastrointestinal tract and on mucosal surfaces. It has a higher pathogenic potential compared to some other non-albicans Candida species and is commonly linked to systemic infections in immunocompromised individuals. In the gut, elevated levels of C. tropicalis may indicate fungal overgrowth, dysbiosis, or a weakened immune system. Its presence in stool tests can help detect imbalances in the gut mycobiome and potential sources of inflammation or infection.
It is a yeast that can normally reside in the gut but may become pathogenic, particularly in individuals with compromised immune systems.
Elevated levels may indicate fungal overgrowth, gut dysbiosis, or underlying health imbalances.
While both can cause infections, C. tropicalis is often more common in bloodstream infections in immunocompromised patients and may exhibit higher resistance to treatment.
Factors include use of antibiotics, immune suppression, high sugar consumption, or chronic illness.